Clinical Trial Update: Hepatitis C Antiviral Resistance in African-Americans [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on antiviral resistance in hepatitis C among African-Americans; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED